Evidence map›Paper›PMID 38928215›Full record

ArticleInternational journal of molecular sciences2024

Gene Expression Reprogramming by Citrate Supplementation Reduces HepG2 Cell Migration and Invasion.

Rocchina Miglionico, Ilenia Matera, Giovanna Maria Ventola, Giovanna Marchese, Vittorio Abruzzese, Magnus Monné, Angela Ostuni, Faustino Bisaccia

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rocchina MiglionicoDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.
Ilenia MateraDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.ORCID 0009-0007-7278-9839
Giovanna Maria VentolaGenomix4Life Srl, 84081 Baronissi, Italy.ORCID 0000-0002-8801-564X
Giovanna MarcheseGenomix4Life Srl, 84081 Baronissi, Italy.
Vittorio AbruzzeseDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.
Magnus MonnéDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.ORCID 0000-0003-2344-3878
Angela OstuniDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.ORCID 0000-0001-5970-5097
Faustino BisacciaDepartment of Sciences, University of Basilicata, 85100 Potenza, Italy.

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca (MIUR), Italy Grant/Award Numbers:PRIN 2017 (2017PAB8EM)
6 · The paper itself

Abstract

Citrate, which is obtained from oxaloacetate and acetyl-CoA by citrate synthase in mitochondria, plays a key role in both normal and cancer cell metabolism. In this work, we investigated the effect of 10 mM extracellular citrate supplementation on HepG2 cells. Gene expression reprogramming was evaluated by whole transcriptome analysis using gene set enrichment analysis (GSEA). The transcriptomic data were validated through analyzing changes in the mRNA levels of selected genes by qRT-PCR. Citrate-treated cells exhibited the statistically significant dysregulation of 3551 genes; 851 genes were upregulated and 822 genes were downregulated. GSEA identified 40 pathways affected by differentially expressed mRNAs. The most affected biological processes were related to lipid and RNA metabolism. Several genes of the cytochrome P450 family were upregulated in treated cells compared to controls, including the

Indexed as

Cell MovementCitric AcidGene Expression Regulation, NeoplasticCarcinoma, HepatocellularGene Expression ProfilingHep G2 CellsHumansLiver NeoplasmsNeoplasm InvasivenessTranscriptomeCitric Acidcitratecytochrome P450 familyGSEAHepG2 cellsRNA-seqtumor aggressiveness

Identifiers

PMID38928215
PMCPMC11203947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.